Cellistic
Sabrina Ascenzo is a seasoned Analytical Development Scientist with a strong background in biochemistry and molecular biology. Sabrina has experience working in various roles in the pharmaceutical and research industries, focusing on analytical method development, quality control, and project management. Sabrina is skilled in conducting quality tests, managing inventory, and implementing continuous improvement strategies. Sabrina holds a Master's degree in Biochemistry and Molecular Biology and has a background in thyroid organogenesis research.
Cellistic
Launched in April 2022, Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company’s focus and expertise in iPSC generation and differentiation protocol development makes it well-positioned to partner with innovative cell therapy developers to establish novel advanced therapies. With more than a decade of scientific and technical knowledge transfer from sister company Ncardia, Cellistic is uniquely experienced in designing and optimizing manufacturing procedures for iPSCs that deliver quality products at scale. For more information, visit www.cellistic.com.